A phase I, abuse liability trial of dasotraline in healthy adult recreational stimulant users
Phase of Trial: Phase I
Latest Information Update: 01 Feb 2016
At a glance
- Drugs Dasotraline (Primary) ; Methylphenidate
- Indications Attention-deficit hyperactivity disorder
- Focus Adverse reactions
- 28 Jan 2016 New trial record
- 25 Jan 2016 Results published online in journal Drug & Alcohol Dependence, according to a Sunovion Pharmaceuticals media release.
- 25 Jan 2016 Results published in a Sunovion Pharmaceuticals media release.